Ledger.Open graph →
SEC Form D · Amendment · filed January 12, 2016

Hapten Sciences, Inc

Offering
$1.7M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MEMPHIS, TN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Stephen L. Bandak · Memphis, TNDirectorRaymond J. Hage · Memphis, TNExec · Director · PromoterGary L. Stevenson · Memphis, TNDirectorGary Prosterman · Memphis, TNExec · Director · PromoterJoseph I. Zakrzewski · Memphis, TNDirectorDavid Cordo · Cambridge, MADirectorMark Azzopardi · Triq il-Qatta Swieqi, O1DirectorCynthia Seidel-Dugan · Cambridge, MADirectorDaniel Hicklin · Cambridge, MAExec · Director · PromoterArnold Oronsky · Cambridge, MAExec · Director · PromoterReid Leonard · Cambridge, MADirectorLuke Evnin · Cambridge, MADirectorSakae Asanuma · Cambridge, MAExec · Director · PromoterWesley Capital Management, LLC · New York, NYExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗